Polyrizon Stock (NASDAQ:PLRZ)
Previous Close
$8.72
52W Range
$2.88 - $18.20
50D Avg
$10.69
200D Avg
$12.75
Market Cap
$9.77M
Avg Vol (3M)
$57.58K
Beta
-1.34
Div Yield
-
PLRZ Company Profile
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from its headquarters in Ra'anana, Israel.